Cite
Ngo D, Benson MD, Long JZ, et al. Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk. JCI Insight. 2021;6(5)doi: 10.1172/jci.insight.144392.
Ngo, D., Benson, M. D., Long, J. Z., Chen, Z. Z., Wang, R., Nath, A. K., Keyes, M. J., Shen, D., Sinha, S., Kuhn, E., Morningstar, J. E., Shi, X., Peterson, B. D., Chan, C., Katz, D. H., Tahir, U. A., Farrell, L. A., Melander, O., Mosley, J. D., Carr, S. A., Vasan, R. S., Larson, M. G., Smith, J. G., Wang, T. J., Yang, Q., & Gerszten, R. E. (2021). Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk. JCI insight, 6(5), . https://doi.org/10.1172/jci.insight.144392
Ngo, Debby, et al. "Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk." JCI insight vol. 6,5 (2021). doi: https://doi.org/10.1172/jci.insight.144392
Ngo D, Benson MD, Long JZ, Chen ZZ, Wang R, Nath AK, Keyes MJ, Shen D, Sinha S, Kuhn E, Morningstar JE, Shi X, Peterson BD, Chan C, Katz DH, Tahir UA, Farrell LA, Melander O, Mosley JD, Carr SA, Vasan RS, Larson MG, Smith JG, Wang TJ, Yang Q, Gerszten RE. Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk. JCI Insight. 2021 Mar 08;6(5). doi: 10.1172/jci.insight.144392. PMID: 33591955; PMCID: PMC8021115.
Copy
Download .nbib